前列腺切除床DCE MRI局灶结节样强化:影像-病理相关性与预后价值
回顾性纳入272例根治性前列腺切除术后1年内行MRI的患者,评估DCE局灶结节样强化与手术切缘阳性(PSM)的一致性及对生化复发(BCR)的预测价值。结果显示强化与PSM位置72.9%一致,并与高Gleason评分、高PSA、切缘Gleason分级4/5及非局限切缘受累相关;在MRI时无BCR者中,强化是1年BCR的独立预测因素(多因素OR=5.49)。
要点
- 术后MRI局灶结节样强化(PI-RR DCE评分≥4)与手术切缘阳性位置高度一致(72.9%)。
- 强化提示不良病理特征:高Gleason评分、高术前PSA、切缘Gleason 4/5、非局限切缘。
- MRI时无BCR者,强化可预测1年BCR(多因素OR=5.49)。
关键影像表现/征象
- 局灶结节样强化在切缘阳性者中占85.4%,阴性者中占14.6%(p<0.001)。
- 强化部位与切缘阳性位置的一致率为72.9%(35/48)。
- 强化与更高Gleason评分、术前PSA≥10 ng/mL、切缘Gleason分级更高及非局限切缘受累相关(p=0.002、0.006、0.032、0.001)。
诊断标准与关键数值
- 局灶结节样强化定义为PI-RR DCE评分≥4。
- 在MRI时无BCR患者中,强化预测1年BCR:单因素OR=8.4(95%CI 2.5-28.3;p=0.001),多因素OR=5.49(95%CI 1.56-19.3;p=0.008)。
临床应用与阅片要点
- 术后MRI报告中应描述DCE局灶结节样强化,提示可能切缘阳性及高复发风险。
- 强化部位应与手术切缘位置对照,辅助定位可疑切缘阳性。
- 对MRI时无BCR但见强化者,可提示临床密切随访BCR。
局限性
- 回顾性单中心设计。
- 仅纳入术后1年内行MRI者,存在选择偏倚可能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To determine the concordance of dynamic contrast-enhanced (DCE) imaging findings with clinico-pathologic characteristics and their prognostic impact for predicting biochemical recurrence (BCR) in patients who underwent radical prostatectomy (RP) for prostate cancer.
METHODS: This retrospective study included patients who underwent MRI within 1 year after RP between November 2019 and October 2020. DCE findings and their concordance with the presence and location of positive surgical margin (PSM) were assessed using RP specimens. Kaplan-Meier and logistic regression analyses were used to evaluate the prognostic impact of DCE findings for BCR.
RESULTS: Among the 272 men (mean age ± standard deviation, 66.6 ± 7.4 years), focal nodular enhancement was more frequently observed in those with PSM compared to those with negative margin (85.4% versus 14.6%; p < 0.001). The sites of focal nodular enhancement were 72.9% (35/48) concordant with the PSM locations. Focal nodular enhancement was associated with a higher Gleason score, higher preoperative PSA (≥ 10 ng/mL), higher Gleason grade at the surgical margin, and non-limited margin involvement (p = 0.002, 0.006, 0.032, and 0.001, respectively). In patients without BCR at the time of MRI, focal nodular enhancement was associated with a shorter time to BCR (p < 0.001) and a significant factor predicting 1-year BCR in both univariate (odds ratio = 8.4 [95% CI: 2.5-28.3]; p = 0.001) and multivariate (odds ratio = 5.49 [1.56-19.3]; p = 0.008) analyses.
CONCLUSIONS: Focal nodular enhancement on post-prostatectomy MRI was associated with adverse clinico-pathologic characteristics of high risk for recurrence and can be a predictor for 1-year BCR in patients undergoing RP.
KEY POINTS: • Focal nodular enhancement (PI-RR DCE score ≥ 4) was 72.9% (35/48) concordant with the site of positive resection margin by radiologic-histologic correlation. • Focal nodular enhancement (PI-RR DCE score ≥ 4) was associated with higher Gleason score ( ≥ 8), preoperative PSA ( > 10 ng/mL), and Gleason grade 4 or 5 at the surgical margin and non-limited margin involvement (p ≤ 0.032). • In patients without BCR at the time of MRI, focal nodular enhancement was a significant factor predicting 1-year BCR (odds ratio = 5.49; 95% CI: 1.56-19.3; p = 0.008).
引用
- Park, Park, Kim, et al. Focal nodular enhancement on DCE MRI of the prostatectomy bed: radiologic-pathologic correlations and prognostic value. Eur Radiol. 2022. PMID: 36350389. doi:10.1007/s00330-022-09241-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。